Nisa Investment Advisors
TERN

Nisa Investment Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Nisa Investment Advisors’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$259K Buy
4,909
+1,511
+44% +$62.1K ﹤0.01% 1128
2025
Q4 		$137K Sell
3,398
-953
-22% -$22K ﹤0.01% 1331
2025
Q3 		$32.7K Hold
4,351
– – ﹤0.01% 1779
2025
Q2 		$16.2K Buy
4,351
+3,953
+993% +$12.3K ﹤0.01% 2041
2025
Q1 		$1.1K Buy
398
+54
+16% +$221 ﹤0.01% 2616
2024
Q4 		$1.91K Buy
344
+191
+125% +$1.29K ﹤0.01% 2501
2024
Q3 		$1.28K Buy
153
+52
+51% +$428 ﹤0.01% 2515
2024
Q2 		$688 Buy
101
+57
+130% +$345 ﹤0.01% 2612
2024
Q1 		$289 Buy
44
+21
+91% +$137 ﹤0.01% 2591
2023
Q4 		$149 Hold
23
– – ﹤0.01% 2588
2023
Q3 		$116 Sell
23
-2
-8% -$13 ﹤0.01% 2726
2023
Q2 		$219 Buy
+25
New +$291 ﹤0.01% 2694

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Nisa Investment Advisors's TERN Position: Q1 2026 in Review

Nisa Investment Advisors increased its Terns Pharmaceuticals (TERN) stake by 44% in Q1 2026, buying an estimated $62.1K and bringing the position to 4,909 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

Nisa Investment Advisors first reported a position in TERN in Q2 2023 and has held it in 12 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Nisa Investment Advisors held 4,909 shares of Terns Pharmaceuticals worth $259K as of Q1 2026.
  • Nisa Investment Advisors bought 1,511 Terns Pharmaceuticals shares in Q1 2026, an estimated $62.1K.
  • Terns Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1128 holding.
  • Nisa Investment Advisors first reported a position in Terns Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.